In the rapidly evolving field of structural biology, determining the precise 3D structures of biological molecules is paramount for understanding their function and developing new therapies. Cryo-electron microscopy (cryo-EM), particularly Single Particle Analysis (SPA), has emerged as a transformative technology, enabling researchers to unveil high-resolution 3D structures of biological macromolecules like proteins and viruses. However, while incredibly powerful, cryo-EM experiments can encounter significant hurdles, especially concerning sample preparation. Addressing these challenges is crucial for advancing structural analysis, and next-generation solutions like GraFuture™ are leading the way in enhancing advanced cryo-EM workflows.

This article explores the challenges inherent in cryo-EM sample preparation and introduces GraFuture™ technology, developed by Shuimu BioSciences, as a cutting-edge solution. We will delve into how GraFuture™, combined with Shuimu's comprehensive, advanced cryo em platform, is pushing the boundaries of resolution and efficiency in structural determination.

For detailed information on how these advanced solutions can accelerate your research, we invite you to visit https://shuimubio.com/.

The Power of Cryo-EM and Its Bottlenecks

Cryo-EM SPA is a powerful approach that integrates cryo-electron microscopy to reveal high-resolution 3D structures of biological macromolecules. This is achieved by collecting numerous 2D images of purified particles and computationally processing them to reconstruct a detailed 3D model. A key advantage of cryo-EM is its ability to preserve samples close to their native state, capture diverse conformations, and require minimal sample volume. It is particularly valuable for determining the structure of heterologous protein complexes. Cryo-EM is vital for life sciences and drug development, providing high-resolution insights into the structure and function of everything from single proteins to complex viruses.

The applications of cryo-EM are vast, spanning areas such as:

· Analyzing biomacromolecules, including membrane proteins (like GPCRs, ion channels, transporters), enzymes, ribosomes, DNA and RNA structures, and protein-nucleic acid complexes.

· Studying viral particles, such as SARS-CoV-2, influenza virus, and African swine fever virus.

· Significant roles in the vaccine field, including viral structure analysis for R&D, vaccine quality control (morphology, particle size, integrity, aggregation), antibody-vaccine interaction studies, and responding to viral mutations.

· Playing a crucial role in antibody drug development, providing structural analysis of antibody-antigen complexes, aiding mechanism of action studies, optimizing and designing antibody drugs, analyzing membrane protein targets, and accelerating the drug development process.

Despite these remarkable capabilities, conventional cryo-EM sample preparation methods face several persistent issues. These include:

· Gas-liquid interface absorption: This can lead to particle denaturation or damage.

· Severe preferred orientation: Many particles align in only a few orientations on the grid, making it difficult to collect a full range of views needed for 3D reconstruction.

· High sample concentration threshold (>1μM): Achieving sufficiently high concentrations for stable sample preparation can be challenging or impossible for some delicate proteins.

· Significant background noise: This can obscure the signal from the target particles.

· Difficulty in reconstructing "small" macromolecular structures: Molecules below a certain size threshold (historically challenging, though Shuimu has achieved structures as small as 51kDa) can be particularly difficult to resolve due to low signal-to-noise ratio and flexibility.

These bottlenecks can limit the types of samples amenable to high-resolution cryo-EM analysis and reduce overall experimental efficiency.

Discover how Shuimu BioSciences is overcoming these limitations with advanced cryo em technologies. Learn more at https://shuimubio.com/.

Introducing GraFuture™: Overcoming Sample Preparation Hurdles

To address the significant challenges posed by traditional support grids in cryo-EM sample preparation, Shuimu BioSciences has developed a series of innovative graphene support grids known as GraFuture™. GraFuture™ offers a potential solution, particularly for the problematic issue of preferred orientation, and is specifically designed for applications involving samples with small protein molecular weight, low concentration, strong background noise, and susceptibility to gas-liquid interface damage.

The GraFuture™ line includes:

· GraFuture™ GO: Graphene oxide support grids.

· GraFuture™ RGO: Reduced graphene oxide support grids.

Choosing GraFuture™ support grids provides several key advantages:

· They are designed to overcome critical challenges like gas-liquid interface issues and preferred orientation, which are notorious obstacles in cryo-EM.

· They enable successful structure determination for challenging samples, including those at low concentrations or with small molecular weights.

By tackling these fundamental sample preparation problems, GraFuture™ grids significantly enhance the likelihood of obtaining high-quality data required for high-resolution structure determination, making previously intractable samples amenable to cryo-EM analysis.

Shuimu BioSciences: A Platform for Advanced Cryo-EM

Shuimu BioSciences, founded in 2017 at Tsinghua University, has quickly established itself as a leader in the field, bringing together world-class experts and cutting-edge technology. As the first commercial platform in Asia offering cryo-EM structure determination, Shuimu's EM Centre is equipped with extensive resources and expertise.

A core strength of Shuimu is its world-class cryo-EM platform. They possess a substantial number of 300 kV instruments – two in Beijing and six in Hangzhou, comprising the world's largest commercial cryo-EM platform. This infrastructure supports 24-hour instrument access, providing researchers with convenient and efficient microscope time for data acquisition. The platform includes state-of-the-art 300 kV cryo-EM instruments equipped with high-performance detectors, energy filters, spherical aberration correctors, and phase plates to ensure maximum imaging quality. Daily maintenance ensures optimal equipment condition, achieving over 330 days of available machine time annually per electron microscope and an annual fault-free operation rate exceeding 97%.

Beyond hardware, Shuimu leverages proprietary AI algorithms. Their independently developed SMART software suite utilizes AI to streamline the cryo-EM data analysis process. This AI-driven approach helps reduce machine runtime, decrease the required data volume, and improve the overall efficiency of data analysis. For cryo-characterization services, their NanoSMART AI system automatically identifies nanoparticle features from images, provides detailed reports, and enhances recognition by clarifying low-quality images. NanoSMART performs excellently in identifying ultra-small targets like VLPs and provides powerful data analysis functions for particle size, roundness, and integrity.

Shuimu's expertise is underpinned by an elite team of PhD-level scientists specializing in structural biology, protein science, and computational biology. They have extensive experience, having completed over 200 cryo-EM projects on diverse samples, including membrane proteins and antigen-antibody complexes. This experience, combined with a relentless pursuit of resolution, has led to impressive results, with more than 150 structures resolved and a best resolution achieved down to a groundbreaking 1.4Å. They have successfully elucidated protein structures as small as 51kDa.

The integration of innovative sample preparation methods like GraFuture™ with Shuimu's robust, advanced cryo em platform, expert team, and AI-driven analysis tools creates a powerful synergy. This allows Shuimu to effectively address challenging projects and consistently deliver high-resolution results.

Explore the full capabilities of Shuimu's advanced cryo em platform, including GraFuture™ technology, at https://shuimubio.com/.

The "One-Stop" Advantage: Gene to Structure

Recognizing that high-quality cryo-EM relies heavily on excellent protein samples, Shuimu BioSciences has also built a complete protein expression and purification platform. This platform encompasses molecular cloning, protein expression, purification, and characterization, minimizing variability often introduced during sample transport and standardizing the entire pipeline. By enhancing these upstream capabilities, Shuimu provides a "One-Stop" solution that covers everything from gene sequences to high-resolution 3D structures.

The protein platform offers various expression systems, including E. coli, mammalian cells, insect cells, and cell-free systems, allowing selection of the optimal system for each target protein. Purification processes utilize techniques like affinity chromatography, ion-exchange chromatography, gel filtration, and RP-HPLC. Protein quality control is rigorous, employing methods such as SDS-PAGE, Western blot, mass spectrometry, thermal stability, and solubility testing. Furthermore, they offer protein assays like SPR, BLI, and ELISA for binding analysis and protein content quantification.

Shuimu's expertise extends particularly to challenging targets like membrane proteins (GPCRs, ion channels, transporters), offering extensive experience in their production and purification. This comprehensive protein capability directly supports their cryo-EM services, ensuring that samples are prepared to the highest standards required for successful structural analysis, potentially utilizing tools like GraFuture™ for optimization when needed.

Request a complimentary project feasibility assessment for your structural biology needs at https://shuimubio.com/.

Applications Enhanced by Advanced Cryo-EM and GraFuture™

The combination of Shuimu's advanced cryo em platform, including cutting-edge technologies like GraFuture™ grids and AI software, unlocks the potential for structural analysis across a wide range of challenging applications.

For samples previously hindered by issues like preferred orientation or low concentration – precisely the problems GraFuture™ aims to mitigate – Shuimu's platform offers renewed possibilities. This is particularly relevant for:

· Membrane proteins: These targets (GPCRs, ion channels, transporters) can be challenging to express and purify in large quantities and are often prone to preferential orientation. Resolving their structures is critical for drug discovery. Shuimu lists numerous membrane proteins on their off-the-shelf protein list, demonstrating expertise in this area.

· Small protein molecular weight targets: While cryo-EM historically struggled with smaller proteins, Shuimu has demonstrated success with targets as small as 51kDa, and GraFuture™ is explicitly mentioned as suitable for small molecular weight samples.

· Flexible complexes: Capturing diverse conformations is an advantage of cryo-EM, but high flexibility can make reconstruction difficult. Tools that improve particle distribution and image quality can aid in resolving such complexes.

Shuimu's extensive experience covers a broad spectrum of sample types, as evidenced by their case studies and resolved structures:

· They have resolved structures of ion channels, GPCRs, antigen-antibody complexes, and spliceosomes, leading to publications in top journals.

· Examples include the human GluN1-GluN2A NMDA receptor bound with small molecules, the histamine H1 receptor/Gq complex, and SARS-CoV-2 related structures.

· Their crystallography service, also part of the comprehensive offerings, has successfully completed over 200 structural analysis projects.

· The MicroED service has successfully delivered over 80% of projects, achieving resolutions of 0.6-1.0Å for small molecules, peptides, and proteins like Proteinase K.

These successes highlight Shuimu's capability in tackling diverse structural challenges, a capability further enhanced by innovations like GraFuture™ support grids and their AI-driven data analysis.

Sample Submission for Advanced Cryo-EM

To ensure successful cryo-EM experiments, meticulous sample preparation and submission are essential. While specific requirements for using GraFuture™ grids are not detailed separately in the sources, general cryo-EM (SPA) sample requirements emphasize quality:

· Protein Solution: Concentration typically ≥ 2mg/mL, volume ≥ 100ul, purity ≥ 90%. Recommendations include minimizing glycosylation/phosphorylation modifications, avoiding repeated freeze-thaw cycles, and using freshly prepared samples.

· Buffer Solution: Should reduce organic solvents like glycerol, with salt ion concentration ≤ 300mM. Volume of 50-100mL is requested.

· Small Molecules: Purity > 95%, require more than 10mg for SPA. DMSO or water can dissolve to >100mM; poor water solubility should reach at least 1mM. Affinity data with the target protein (nanomolar level) should be provided. Fresh samples are recommended, sent frozen with dry ice, and not thawed in advance.

For Negative Staining, different requirements apply due to the nature of the technique:

· Protein Purity: >95%, with no significant impurities or degradation bands on SDS-PAGE.

· Uniformity: Sample should ideally pass through a molecular sieve with a single peak (>90% uniformity). Do not concentrate after molecular sieving.

· Volume and Concentration: 50ul-100ul (single use) at a concentration of 0.01-0.02 mg/ml.

· Buffer: Should not contain polysaccharides, DMSO, glycerol, or other organic substances, with salt ion concentration below 300 mM.

· Aliquot samples to avoid repeated freeze-thaw cycles.

For Cryo-Characterization of nanoparticles like LNPs, liposomes, and viruses:

· Liposomes: 1mg/ml suggested.

· Viruses (e.g., AAV): Suggested 1e13 power, at least 50μl/sample.

· Micelle/LNP: Concentration needs exploration; LNP suggested increase to around 10mg/ml (low concentration like 3mg/ml may not enter the hole).

· Sugar content: <10%, higher affects contrast.

For MicroED, the sample requirements are specific for crystals:

· Sample Type: Small molecules, peptides, or proteins in crystal form.

· Sample State: Powder or lump acceptable.

· Quality: ≥ 5mg (or visible to the naked eye if not). Samples must be stable crystals.

Timely communication with the operations manager or sales colleague is consistently recommended for sample submission across different services to coordinate experiments promptly. For cryo-samples, delivery at least 1 working day in advance is required.

While GraFuture™ specifically addresses issues like preferred orientation and low concentration, adhering to the general purity and buffer requirements for the initial sample is still crucial for optimal grid preparation. Shuimu's integrated protein preparation services can assist clients in producing samples that meet these stringent requirements.

Learn more about specific sample requirements for your project and discuss the potential benefits of GraFuture™ and other advanced cryo em techniques with Shuimu's experts by visiting https://shuimubio.com/.

Conclusion: Advancing Structural Biology with GraFuture™ and Shuimu BioSciences

The structural determination of biological macromolecules using cryo-EM is a cornerstone of modern life sciences and drug discovery. As researchers push the boundaries to study more challenging targets – smaller proteins, flexible complexes, membrane proteins, and samples available only at low concentrations – innovations in sample preparation are essential.

GraFuture™ graphene support grids represent a significant step forward, directly addressing critical bottlenecks like preferred orientation and sample-air interface damage that can impede high-resolution structural analysis. By providing a more favorable environment for sample deposition, GraFuture™ enhances the efficiency and accuracy of data collection for difficult samples.

Paired with Shuimu BioSciences's extensive advanced cryo em capabilities – including the world's largest commercial 300 kV platform, elite scientific team, cutting-edge AI-driven software, and comprehensive one-stop protein services – GraFuture™ is part of a powerful ecosystem dedicated to accelerating structural biology research. From gene sequence to high-resolution 3D structure, Shuimu offers integrated solutions designed to tackle complex projects and deliver exceptional results. Their track record of resolved structures published in leading journals speaks to their expertise and the quality of their services.

By leveraging innovative technologies like GraFuture™ and Shuimu's integrated, advanced cryo em services, researchers can overcome previous limitations and gain unprecedented insights into the molecular world, driving forward drug discovery, vaccine development, and fundamental biological understanding.

To discover how GraFuture™ and Shuimu BioSciences's advanced cryo em solutions can empower your research and help you resolve challenging structures, visit https://shuimubio.com/ and contact their expert team.